Susan Hogan to C-Reactive Protein
This is a "connection" page, showing publications Susan Hogan has written about C-Reactive Protein.
Connection Strength
0.117
-
Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis. Pharmacotherapy. 2005 Mar; 25(3):335-44.
Score: 0.054
-
Preston GA, Barrett CV, Alcorta DA, Hogan SL, Dinwiddie L, Jennette JC, Falk RJ. Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels. Nephron. 2002 Dec; 92(4):817-23.
Score: 0.046
-
Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Ann Pharmacother. 2008 Jan; 42(1):9-15.
Score: 0.016